[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1021 Introduced in House (IH)]







104th CONGRESS
  1st Session
                                H. R. 1021

 To require the Secretary of Health and Human Services to increase the 
voting consumer representation of the Blood Products Advisory Committee 
      of the Food and Drug Administration, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 23, 1995

 Mr. Goss (for himself, Mr. Quillen, Mr. Engel, Mrs. Meek, of Florida, 
Mr. Stearns, Mr. Hilliard, Mr. English of Pennsylvania, Mr. Gejdenson, 
  Mr. Calvert, Mr. Markey, Ms. Furse, Mr. Bartlett of Maryland, Mrs. 
   Fowler, and Mr. Nadler) introduced the following bill; which was 
                 referred to the Committee on Commerce

_______________________________________________________________________

                                 A BILL


 
 To require the Secretary of Health and Human Services to increase the 
voting consumer representation of the Blood Products Advisory Committee 
      of the Food and Drug Administration, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Blood Products Advisory Committee 
Act of 1995''.

SEC. 2. CONSUMER REPRESENTATION ON THE BLOOD PRODUCTS ADVISORY 
              COMMITTEE.

    The Secretary of Health and Human Services shall ensure that not 
less than \1/3\ of the voting members of the Blood Products Advisory 
Committee shall be--
            (1) individuals who have received blood products but not in 
        connection with a professional or commercial activity; and
            (2) representatives of consumer organizations with 
        expertise in blood products.
                                 <all>